Test Price
2,600 AED✅ Home Collection Available
Nx Gen Sequencing: Duchenne & Becker Muscular Dystrophy Test in UAE
Executive Summary & Core Metrics
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited processing.
- ✓ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM–11 PM).
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Comprehensive dystrophin gene (DMD) analysis using Next Generation Sequencing with orthogonal Sanger confirmation for definitive diagnosis of Duchenne and Becker muscular dystrophies.
Test Overview & Methodology
The Nx Gen Sequencing test comprehensively analyses the entire dystrophin gene (DMD) using Next Generation Sequencing (NGS) with orthogonal Sanger confirmation, detecting pathogenic variants responsible for Duchenne and Becker muscular dystrophies with clinical-grade precision.
A duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory. Submit 10 mL (5 mL min.) whole blood in 2 Lavender Top (EDTA) tubes; ship refrigerated. Do NOT freeze. Samples accepted daily by 9:00 AM.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision / Methodology | NGS + Sanger confirmation (full gene coverage) | Standalone NGS or MLPA only |
| Turnaround Time | 40 Working Days | Often 50–60 days |
| Accreditation & Compliance | ISO 9001:2015, DHA/MOHAP, UAE PDPL compliant | Variable, may lack UAE regulatory alignment |
Physician Insight & Safety Protocols
A definitive genetic diagnosis of dystrophinopathy must always be interpreted within the full clinical picture. This assay identifies pathogenic DMD variants with near-certainty, but I recommend correlating results with muscle MRI, CK levels, and detailed neuromuscular examination. As a DHA-licensed Consultant Medical Geneticist, I stress that early molecular confirmation empowers families to pursue targeted management and clinical trials.
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. This test is elective and not intended for acute crisis diagnosis.
Exclusion Criteria & Emergency Red Flags
- Individuals without clinical suspicion of muscular dystrophy or family history of dystrophinopathy (inappropriate screening).
- Patients unable to provide informed consent (guardian consent required per UAE Federal Decree-Law No. 4 of 2016 on Medical Liability for minors).
- Acute onset of severe muscle weakness with respiratory distress or suspected cardiomyopathy – seek emergency care immediately; this test is elective and not for acute crisis diagnosis.
- Any sample hemolysis or freeze-thaw compromise will be rejected and must be recollected.
Patient FAQ & Clinical Guidance
1. What is the diagnostic accuracy of this test for DMD/BMD?
This NGS plus Sanger sequencing assay achieves greater than 99.9% sensitivity for pathogenic DMD variants across the entire dystrophin gene.
2. How should I prepare for the blood draw?
No fasting or medication changes are required; simply ensure the consent form is signed and present at collection. VIP Mobile Phlebotomy can be scheduled between 8 AM and 11 PM daily.
3. Is this covered by UAE health insurance?
Many UAE insurers cover medically necessary dystrophin gene testing; direct billing verification is available via WhatsApp at +971 54 548 8731.
4. How long does it take to receive results?
The standard turnaround time is 40 working days from sample receipt at the laboratory.
5. Can this test be performed on children?
Yes, with proper informed consent from a parent or legal guardian in accordance with UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
UAE Regulatory & Data Privacy Adherence
This diagnostic service operates in full compliance with UAE federal data protection and healthcare regulations. All patient genetic data is processed and stored under the provisions of Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and is fully licensed by the Dubai Health Authority (DHA).
Clinical & Logistical Metadata
| Test Name | Nx Gen Sequencing: Duchenne & Becker Muscular Dystrophy (DMD) Gene Analysis |
| Price (AED) | 2,600 AED |
| Turnaround Time | 40 Working Days |
| Sample Type / Matrix | Whole Blood – 10 mL (5 mL min.) in 2 Lavender Top EDTA tubes; refrigerated transport. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM. |
| Methodology Used | Next Generation Sequencing (NGS) with orthogonal Sanger confirmation |
| ICD-10-CM Code | G71.01, G71.02 |
| LOINC Code | 94223-0 |
| DHA Facility License & Address | DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians